HEXO Stock Overview
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada.
HEXO Corp. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||CA$0.18|
|52 Week High||CA$2.06|
|52 Week Low||CA$0.17|
|1 Month Change||-13.30%|
|3 Month Change||-11.77%|
|1 Year Change||-90.67%|
|3 Year Change||-98.83%|
|5 Year Change||-97.37%|
|Change since IPO||-96.99%|
Recent News & Updates
Hexo to produce Mike Tyson's cannabis brand's products in Canada
Hexo (NASDAQ:HEXO) said it signed an exclusive partnership with Mike Tyson's recently formed cannabis company TYSON 2.0. Under the agreement, Hexo will produce TYSON 2.0's products in Canada, including full range of flower, pre-rolls, edibles and vapes. The HEXO-produced lines will launch across Canada in fall 2022, the company said in an Aug. 30 press release. "With their broad product range from flower to straight edge pre-rolls to edibles, the TYSON 2.0 brand fits perfectly into HEXO's market leading portfolio," said Hexo CEO Charlie Bowman. HEXO +4.67% to $0.22 premarket Aug. 30
Canopy Growth, Tilray other Canadian cannabis names up amid WallStreetBets chatter
Canopy Growth (NASDAQ:CGC), Tilray Brands (NASDAQ:TLRY), and other Canadian cannabis licensed producers are markedly higher in Wednesday trading as chatter about the industry on WallStreetBets intensifies. In Wednesday morning trading, Canopy (CGC) is up 11%, Tilray (TLRY) up 4%, Aurora Cannabis (NASDAQ:ACB) up 6%, and HEXO Corp. (NASDAQ:HEXO) up 11%. There is increased discussion about Canadian LPs on WallStreetBets which may account for the increases. Tilray (TLRY) CEO Irwin Simon, in a recent interview with Yahoo Finance, said that the U.S. represents in $100B opportunity in cannabis. That opportunity could become reality if a federal marijuana legalization bill gets signed into law. Check out a recent deep dive into Tilray (TLRY) and whether the stock is a buy at this time.
HEXO receives additional 180 calendar day grace period for regaining compliance
HEXO (NASDAQ:HEXO) received an extension of 180 calendar days post expiration of initial 180 calendar days period to regain minimum bid price requirement compliance on July 25, 2022 from the Nasdaq Stock Market. The company now has time until Jan.23, 2023 to regain compliance after which the company is likely to receive notification for shares delisting. The current notification has no impact on the listing.
|HEXO||US Pharmaceuticals||US Market|
Return vs Industry: HEXO underperformed the US Pharmaceuticals industry which returned 3% over the past year.
Return vs Market: HEXO underperformed the US Market which returned -23.7% over the past year.
|HEXO Average Weekly Movement||11.6%|
|Pharmaceuticals Industry Average Movement||11.5%|
|Market Average Movement||6.9%|
|10% most volatile stocks in US Market||15.7%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: HEXO is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: HEXO's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names.
HEXO Corp. Fundamentals Summary
|HEXO fundamental statistics|
Is HEXO overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|HEXO income statement (TTM)|
|Cost of Revenue||CA$223.91m|
Last Reported Earnings
Apr 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-1.73|
|Net Profit Margin||-556.49%|
How did HEXO perform over the long term?See historical performance and comparison